NCT05879978
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05879978
Title A Study to Test How Well Different Doses of BI 764532 in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA | DEU | BEL

Facility Status City State Zip Country Details
Cliniques Universitaires Saint-Luc Brussels 1200 Belgium Details
UNIV UZ Gent Ghent 9000 Belgium Details
HOP Louis Pradel Bron 69677 France Details
CTR François Baclesse Caen 14000 France Details
INS Claudius Regaud IUCT-Oncopole Toulouse 31059 France Details
Technische Universität Dresden Dresden 01307 Germany Details
Universitätsklinikum Frankfurt Frankfurt 60590 Germany Details
National Cancer Center Hospital Tokyo, Chuo-ku 104-0045 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field